Kaplan-Meier and Log-rank tests showed that S-CEA and recombined p53 had significant differences for OS and DFS of CRC, whereas single p53 and combined p53 showed limited effectiveness for prognostic values, which is consistent with some published literature (15, 31). The gene discussed is CEACAM5; the disease is colorectal carcinoma.